Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination - a case study

Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination - a case study

Vaccinated convalescents do not develop severe COVID-19 after infection with new SARS-CoV-2 variants. We questioned how messenger RNA (mRNA) vaccination of convalescents provides protection from emerging virus variants. From the cohort of 71 convalescent plasma donors, we identified a patient who de...

Full description

Bibliographic Details
Main Authors: Erlend Ravlo, Aleksandr Ianevski, Eirin Starheim, Wei Wang, Ping Ji, Hilde Lysvand, Teemu Smura, Gaily Kivi, Maia-Liisa Voolaid, Kati Plaan, Mart Ustav, Mart Ustav, Jr., Eva Zusinaite, Tanel Tenson, Reet Kurg, Valentyn Oksenych, Kirsti Walstad, Svein Arne Nordbø, Mari Kaarbø, Karin Ernits, Magnar Bjørås, Denis E. Kainov, Mona Høysæter Fenstad
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:International Journal of Infectious Diseases
Subjects:
SARS-CoV-2
COVID-19
mRNA vaccination
Immune response
Neutralizing antibody
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971223007488

Internet

http://www.sciencedirect.com/science/article/pii/S1201971223007488

Similar Items